Company Profile

Ichor Medical Systems Inc
Profile last edited on: 3/10/2021      CAGE: 8AMK4      UEI: Q2Z1EV1XZWX9

Business Identifier: Electroporation-mediated DNA drug delivery systems
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

6310 Nancy Ridge Drive Suite 107
San Diego, CA 92121
   (858) 550-2022
Location: Single
Congr. District: 52
County: San Diego

Public Profile

Ichor Medical Systems, Inc. is a biotechnology company organized around the clinical application and commercialization of electroporation-mediated DNA drug delivery systems. The company offers TriGrid Delivery System for delivery of DNA drugs and vaccines to treat diseases, such as pandemic flu, hepatitis B, HIV, melanoma, and multiple sclerosis. Ichor Medical Systems' TriGrid™ Delivery System (TriGrid) is the first integrated and fully automated device for electroporation-mediated DNA administration in humans. Ichor is collaborating with partners to provide its enabling TriGrid platform as a means for delivery of DNA drugs and vaccines in disease indications such as cancer, malaria, hepatitis B virus (HBV) infection, human papillomavirus (HPV) infection, human immunodeficiency virus (HIV) infection, and Ebola, as well as for multiple biodefense agents. Funded by DARPA, the TriGrid platform is also being developed for DNA-based antibody delivery as a rapid countermeasure in the event of an infectious outbreak or biological weapons attack.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Robert M Bernard -- Co-Founder, President and CEO

  May De Las Alas -- Director, Business Development

  Claire F Evans -- Director, Therapeutic Programs

  Drew Hannaman -- Vice President, Research and Development

  Brian D Livingston

  Alain T Luxembourg

  Edward M Nolan

  May D Pidding -- Director, Business Development

  Jeffrey Walker